Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group.
Ewing sarcoma
bone sarcoma
chondrosarcoma
local recurrence
osteosarcoma
unplanned surgery
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
06
2020
accepted:
05
08
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
30
10
2020
Statut:
epublish
Résumé
The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries. Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months. The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively. We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS.
Sections du résumé
BACKGROUND
BACKGROUND
The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries.
PATIENTS AND METHODS
METHODS
Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months.
RESULTS
RESULTS
The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively.
CONCLUSION
CONCLUSIONS
We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS.
Identifiants
pubmed: 33116858
doi: 10.2147/CMAR.S270178
pii: 270178
pmc: PMC7567545
doi:
Types de publication
Journal Article
Langues
eng
Pagination
10017-10022Informations de copyright
© 2020 Nakamura et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare for this work.
Références
Sci Rep. 2016 Dec 08;6:38783
pubmed: 27929143
Clin Orthop Relat Res. 2010 Nov;468(11):3028-34
pubmed: 20496020
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95
pubmed: 30285218
Eur Radiol. 2004 Mar;14(3):506-13
pubmed: 14557894
Acta Orthop Scand. 1998 Jun;69(3):230-6
pubmed: 9703394
J Surg Oncol. 2015 Jun;111(8):957-61
pubmed: 26040553
Skeletal Radiol. 2013 May;42(5):611-26
pubmed: 23053201
JAAPA. 2016 Dec;29(12):29-35
pubmed: 27846188
J Surg Oncol. 2009 Nov 1;100(6):484-7
pubmed: 19653261
J Surg Oncol. 2019 Sep;120(4):746-752
pubmed: 31286523
Jpn J Clin Oncol. 2017 Nov 1;47(11):1055-1059
pubmed: 28973287
Bone Joint J. 2014 May;96-B(5):665-72
pubmed: 24788503
J Surg Res. 2017 Feb;208:26-32
pubmed: 27993214
Skeletal Radiol. 2013 Aug;42(8):1097-104
pubmed: 23685708
Cancer. 2006 Jun 15;106(12):2701-6
pubmed: 16691623
J Orthop Sci. 2017 Jan;22(1):133-143
pubmed: 27847134
J Surg Oncol. 2006 Dec 1;94(7):592-8
pubmed: 17066433
Injury. 2002 Jul;33(6):533-8
pubmed: 12098554
Clin Orthop Relat Res. 2008 Dec;466(12):3093-100
pubmed: 18818981